Site Sponsors
  • Park Systems - Manufacturer of a complete range of AFM solutions
  • Strem Chemicals - Nanomaterials for R&D
  • Oxford Instruments Nanoanalysis - X-Max Large Area Analytical EDS SDD
Posted in | Nanobusiness

Nanotechnology Investment Company Commences U.S. Trading of ADRs

Published on October 21, 2010 at 12:28 AM

Nanostart AG (fwb:NNS), the Frankfurt-based nanotechnology investment company, announced the commencement of trading today of its American Depositary Receipts (ADRs), which will now trade in the United States on the OTCQX electronic trading system under the ticker symbol NASRY.

With this step, Nanostart ADRs can now be traded on the world's largest capital market, the United States, like any other U.S. security: during U.S. market hours, with pricing and settlement in U.S. dollars, and with normal custody in U.S. brokerage accounts.

ADRs are securities issued by a U.S. depositary bank which certify ownership of the shares of an international company held in safekeeping by the bank. Because they are U.S. domestic securities, ADRs are a convenient alternative to direct ownership of foreign equities. The depositary bank for the ADRs of Nanostart AG, which is a Sponsored Level 1 program, is Bank of New York Mellon. Ten Nanostart ADRs correspond to one Nanostart share.

"The admission of our ADRs for trading on the OTCQX offers many of the benefits of a full U.S. exchange listing, but without the associated high costs and legal burden," explained Marco Beckmann, CEO of Nanostart AG. "Through the ADR program, U.S. investors gain access to foreign equities through the domestic U.S. market system. The U.S. capital market opens a whole new dimension for international companies."

"Companies use OTCQX to expand their access to investors, engage them with quality disclosure of their financials, and provide trading transparency to stimulate liquidity," said R. Cromwell Coulson, President and CEO of Pink OTC Markets Inc., parent of the trading system. "We are pleased to welcome Nanostart to OTCQX."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit